Skip to main content

Oragenics Inc

OGEN
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001174940

No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.

Q2 2025 vs. Q1 2025

How the institutions holding Oragenics Inc changed between Q1 2025 and Q2 2025.

All holders in Q2 2025All holders in Q1 2025

13F holders of OGEN: Q1 2025 compared with Q2 2025
MeasureQ1 2025Q2 2025Change
Holders2218−4
Shares273.4K105.3K−168.2K (−61.5%)
Value$57.2K$401.6K+$344.4K (+601.9%)

New holders (5)

Institutions that held Oragenics Inc at the end of Q2 2025 but not at the end of Q1 2025.

Institutions new to OGEN in Q2 2025
InstitutionSharesValue% of portfolio
Clear Street LLC70,619$269.8K0.00%
FNY Investment Advisers, LLC2,500$9.00K0.00%
Wells Fargo & Company34$1300.00%
Harbour Investments, Inc.34$1300.00%
Strategic Wealth Partners, Ltd.1$40.00%

Sold out (9)

Institutions that held Oragenics Inc at the end of Q1 2025 and filed for Q2 2025 without it.

Institutions that sold out of OGEN in Q2 2025
InstitutionShares, Q1 2025Value, Q1 2025
Geode Capital Management, LLC84,826$17.8K
GSB Wealth Management, LLC30,927$6.50K
Two Sigma Securities, LLC25,107$5.27K
XTX Topco Ltd24,845$5.22K
Two Sigma Investments, LP18,231$3.83K
Mutual Advisors, LLC16,000$3.15K
HBK Sorce Advisory LLC13,626$2.86K
Hexagon Capital Partners LLC275$58
GWM Advisors LLC1$0